Back to Journals » ClinicoEconomics and Outcomes Research » Volume 10

ClinicoEconomics and Outcomes Research


Archive: Volume 10, 2018

Cost effectiveness of ixekizumab versus secukinumab in the treatment of moderate-to-severe plaque psoriasis in Spain

Johansson E, Nuñez M, Svedbom A, Dilla T, Hartz S

ClinicoEconomics and Outcomes Research 2018, 10:747-759

Published Date: 12 November 2018

Cost-utility of surgical sutureless bioprostheses vs TAVI in aortic valve replacement for patients at intermediate and high surgical risk

Povero M, Miceli A, Pradelli L, Ferrarini M, Pinciroli M, Glauber M

ClinicoEconomics and Outcomes Research 2018, 10:733-745

Published Date: 8 November 2018

Cost-consequence model comparing eltrombopag and romiplostim in pediatric patients with chronic immune thrombocytopenia

Tremblay G, Dolph M, Bhor M, Said Q, Roy A, Elliott B, Briggs A

ClinicoEconomics and Outcomes Research 2018, 10:715-721

Published Date: 5 November 2018

Cost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopenia

Tremblay G, Dolph M, Bhor M, Said Q, Elliott B, Briggs A

ClinicoEconomics and Outcomes Research 2018, 10:705-713

Published Date: 1 November 2018

Incremental health care resource utilization and expenditures associated with autosomal dominant polycystic kidney disease

Iyer NN, Vendetti NJ, Levy DI, Mardekian J, Mychaskiw MA, Thomas III J

ClinicoEconomics and Outcomes Research 2018, 10:693-703

Published Date: 31 October 2018

Burden of cancer pain in developing countries: a narrative literature review

Li Z, Aninditha T, Griene B, Francis J, Renato P, Serrie A, Umareddy I, Boisseau S, Hadjiat Y

ClinicoEconomics and Outcomes Research 2018, 10:675-691

Published Date: 2 November 2018

Economic benefits of implementing patient-centered medical home among patients with hypertension

Almalki ZS, Alotaibi AA, Alzaidi WS, Alghamdi AA, Bahowirth AM, Alsalamah NM

ClinicoEconomics and Outcomes Research 2018, 10:665-673

Published Date: 31 October 2018

Economic analysis of pharmacist-administered influenza vaccines in Ontario, Canada

O'Reilly DJ, Blackhouse G, Burns S, Bowen JM, Burke N, Mehltretter J, Waite NM, Houle SKD

ClinicoEconomics and Outcomes Research 2018, 10:655-663

Published Date: 24 October 2018

Real-world analysis of cost, health care resource utilization, and supportive care in Hodgkin lymphoma patients with frontline failure

Bonafede M, Feliciano J, Cai Q, Noxon V, Princic N, Richhariya A, Straus DJ

ClinicoEconomics and Outcomes Research 2018, 10:629-641

Published Date: 17 October 2018

Impact of antiepileptic-drug treatment burden on health-care-resource utilization and costs

Rajagopalan K, Candrilli SD, Ajmera M

ClinicoEconomics and Outcomes Research 2018, 10:619-627

Published Date: 16 October 2018

The role of a best practice alert in the electronic medical record in reducing repetitive lab tests

Bejjanki H, Mramba LK, Beal SG, Radhakrishnan N, Bishnoi R, Shah C, Agrawal N, Harris N, Leverence R, Rand K

ClinicoEconomics and Outcomes Research 2018, 10:611-618

Published Date: 8 October 2018

Does knowledge of patient non-compliance change prescribing behavior in the real world? A claims-based analysis of patients with serious mental illness

Shafrin J, Bognar K, Everson K, Brauer M, Lakdawalla DN, Forma FM

ClinicoEconomics and Outcomes Research 2018, 10:573-585

Published Date: 2 October 2018

Societal costs due to meningococcal disease: a national registry-based study

Gustafsson N, Stallknecht SE, Skovdal M, Poulsen PB, Østergaard L

ClinicoEconomics and Outcomes Research 2018, 10:563-572

Published Date: 2 October 2018

Impact of a pharmacist-led diabetes management on outcomes, utilization, and cost

Maeng DD, Graham J, Bogart M, Hao J, Wright EA

ClinicoEconomics and Outcomes Research 2018, 10:551-562

Published Date: 24 September 2018

Cost of acute cough in Italian children

Dal Negro RW, Turco P, Povero M

ClinicoEconomics and Outcomes Research 2018, 10:529-537

Published Date: 17 September 2018

Propensity score matching comparison of laparoscopic versus open surgery for rectal cancer in a middle-income country: short-term outcomes and cost analysis

Tayar DO, Ribeiro Jr U, Cecconello I, Magalhães TM, Simões CM, Auler Jr JOC

ClinicoEconomics and Outcomes Research 2018, 10:521-527

Published Date: 12 September 2018

Cost-effectiveness analysis of voriconazole, fluconazole, and amphotericin B for invasive fungal infections following allogeneic hematopoietic stem cell transplantation in Mexico

Morfín-Otero R, Alvarado-Ibarra M, Rodriguez-Noriega E, Resendiz-Sanchez J, Patel DA, Stephens JM, Di Fusco M, Mendoza CF, Charbonneau C

ClinicoEconomics and Outcomes Research 2018, 10:511-520

Published Date: 6 September 2018

Cost–consequence analysis of fluticasone furoate/vilanterol 92/22 mcg for the management of COPD in the Spanish NHS

Vallejo-Aparicio LA, Peces-Barba G, Gil A, Huerta Hernandez A

ClinicoEconomics and Outcomes Research 2018, 10:501-510

Published Date: 5 September 2018

Incidence of febrile neutropenia during chemotherapy among patients with nonmyeloid cancer receiving filgrastim vs a filgrastim biosimilar

Schwartzberg LS, Lal LS, Balu S, Campbell K, Brekke L, Elliott C, Korrer S

ClinicoEconomics and Outcomes Research 2018, 10:493-500

Published Date: 3 September 2018

Obesity in Germany and Italy: prevalence, comorbidities, and associations with patient outcomes

DiBonaventura M, Nicolucci A, Meincke H, Le Lay A, Fournier J

ClinicoEconomics and Outcomes Research 2018, 10:457-475

Published Date: 24 August 2018

Relapse prevention: a cost-effectiveness analysis of brexpiprazole treatment in adult patients with schizophrenia in the USA

Aigbogun MS, Liu S, Kamat SA, Sapin C, Duhig AM, Citrome L

ClinicoEconomics and Outcomes Research 2018, 10:443-456

Published Date: 16 August 2018

Cost of opioid medication abuse with and without tampering in the USA

Vietri J, Masters ET, Barsdorf AI, Mardekian J

ClinicoEconomics and Outcomes Research 2018, 10:433-442

Published Date: 10 August 2018

The burden of cystic fibrosis in the Medicaid population

Hassan M, Bonafede MM, Limone BL, Hodgkins P, Sawicki GS

ClinicoEconomics and Outcomes Research 2018, 10:423-431

Published Date: 25 July 2018

Cost-minimization analysis of degludec/liraglutide versus glargine/aspart: economic implications of the DUAL VII study outcomes

Torre E, Bruno GM, Di Matteo S, Martinotti C, Oselin M, Valentino MC, Parodi A, Bottaro LC, Colombo GL

ClinicoEconomics and Outcomes Research 2018, 10:413-421

Published Date: 26 July 2018

Impact of comorbidity on the risk and cost of hospitalization in HIV-infected patients: real-world data from Abruzzo Region

Cammarota S, Citarella A, Manzoli L, Flacco ME, Parruti G

ClinicoEconomics and Outcomes Research 2018, 10:389-398

Published Date: 23 July 2018

Health-care utilization and outcomes of patients at high risk of invasive fungal infection

Fu R, Gundrum J, Sung AH

ClinicoEconomics and Outcomes Research 2018, 10:371-387

Published Date: 12 July 2018

A cost–benefit analysis of smoking cessation prescription coverage from a US payer perspective

Baker CL, Ding Y, Ferrufino CP, Kowal S, Tan J, Subedi P

ClinicoEconomics and Outcomes Research 2018, 10:359-370

Published Date: 16 July 2018

Evaluation of statin utilization in the Republic of Macedonia during 2013–2016

Naumovska Z, Nestorovska AK, Grozdanova A, Hristova K, Dimovski A, Suturkova L, Sterjev Z

ClinicoEconomics and Outcomes Research 2018, 10:339-347

Published Date: 26 June 2018

Cost-effectiveness analysis of treating transplant-eligible multiple myeloma patients in Macedonia

Qerimi V, Kapedanovska Nestorovska A, Sterjev Z, Genadieva-Stavric S, Suturkova L

ClinicoEconomics and Outcomes Research 2018, 10:327-338

Published Date: 20 June 2018

The cost of dysphagia in geriatric patients

Westmark S, Melgaard D, Rethmeier LO, Ehlers LH

ClinicoEconomics and Outcomes Research 2018, 10:321-326

Published Date: 6 June 2018

A comparison between WHODAS 2.0 and Modified Barthel Index: which tool is more suitable for assessing the disability and the recovery rate in orthopedic rehabilitation?

Galli T, Mirata P, Foglia E, Croce D, Porazzi E, Ferrario L, Ricci E, Garagiola E, Pagani R, Banfi G

ClinicoEconomics and Outcomes Research 2018, 10:301-307

Published Date: 5 June 2018

Cost-effectiveness of pulse-echo ultrasonometry in osteoporosis management

Soini E, Riekkinen O, Kröger H, Mankinen P, Hallinen T, Karjalainen JP

ClinicoEconomics and Outcomes Research 2018, 10:279-292

Published Date: 29 May 2018

Intermittent pneumatic compression is a cost-effective method of orthopedic postsurgical venous thromboembolism prophylaxis

Saunders R, Comerota AJ, Ozols A, Torrejon Torres R, Ho KM

ClinicoEconomics and Outcomes Research 2018, 10:231-241

Published Date: 19 April 2018

The economic and clinical burden of early versus late initiation of celecoxib among patients with osteoarthritis

Shelbaya A, Solem CT, Walker C, Wan Y, Johnson C, Cappelleri JC

ClinicoEconomics and Outcomes Research 2018, 10:213-222

Published Date: 6 April 2018

Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: pooled analysis in 4 Basque Country university hospitals

Martínez del Prado P, Alvarez-López I, Domínguez-Fernández S, Plazaola A, Ibarrondo O, Galve-Calvo E, Ancizar-Lizarraga N, Gutierrez-Toribio M, Lahuerta-Martínez A, Mar J

ClinicoEconomics and Outcomes Research 2018, 10:189-199

Published Date: 19 March 2018

Cost analysis of pulmonary lobectomy procedure: comparison of stapler versus precision dissection and sealant [Corrigendum]

Droghetti A, Marulli G, Vannucci J, Giovanardi M, Bottoli MC, Ragusa M, Muriana G

ClinicoEconomics and Outcomes Research 2018, 10:155-156

Published Date: 13 March 2018

Modeling the economic outcomes of immuno-oncology drugs: alternative model frameworks to capture clinical outcomes

Gibson EJ, Begum N, Koblbauer I, Dranitsaris G, Liew D, McEwan P, Tahami Monfared AA, Yuan Y, Juarez-Garcia A, Tyas D, Lees M

ClinicoEconomics and Outcomes Research 2018, 10:139-154

Published Date: 8 March 2018

Clinical and economic burden of idiopathic pulmonary fibrosis in Quebec, Canada

Tarride JE, Hopkins RB, Burke N, Guertin JR, O'Reilly D, Fell CD, Dion G, Kolb M

ClinicoEconomics and Outcomes Research 2018, 10:127-137

Published Date: 22 February 2018

Early laparoscopic cholecystectomy is more cost-effective than delayed laparoscopic cholecystectomy in the treatment of acute cholecystitis

Kerwat D, Zargaran A, Bharamgoudar R, Arif N, Bello G, Sharma B, Kerwat R

ClinicoEconomics and Outcomes Research 2018, 10:119-125

Published Date: 19 February 2018

A cost-utility analysis of small bite sutures versus large bite sutures in the closure of midline laparotomies in the United Kingdom National Health Service

Gokani SA, Elmqvist KO, El-Koubani O, Ash J, Biswas SK, Rigaudy M

ClinicoEconomics and Outcomes Research 2018, 10:105-117

Published Date: 19 February 2018

Oral versus intravenous iron therapy in patients with inflammatory bowel disease and iron deficiency with and without anemia in Germany – a real-world evidence analysis

Stein J, Haas JS, Ong SH, Borchert K, Hardt T, Lechat E, Nip K, Foerster D, Braun S, Baumgart DC

ClinicoEconomics and Outcomes Research 2018, 10:93-103

Published Date: 5 February 2018

Systematic review of health state utility values for acute myeloid leukemia

Forsythe A, Brandt PS, Dolph M, Patel S, Rabe APJ, Tremblay G

ClinicoEconomics and Outcomes Research 2018, 10:83-92

Published Date: 25 January 2018

The preventive effect on respiratory tract infections of Oscillococcinum®. A cost-effectiveness analysis

Colombo GL, Di Matteo S, Martinotti C, Oselin M, Bruno GM, Beghi GM

ClinicoEconomics and Outcomes Research 2018, 10:75-82

Published Date: 23 January 2018

Pain associated with health and economic burden in France: results from recent National Health and Wellness Survey data

Hadjiat Y, Serrie A, Treves R, Chomier B, Geranton L, Billon S

ClinicoEconomics and Outcomes Research 2018, 10:53-65

Published Date: 18 January 2018

Economic evaluation of spondyloarthritis: economic impact of diagnostic delay in Italy

Mennini FS, Viti R, Marcellusi A, Sciattella P, Viapiana O, Rossini M

ClinicoEconomics and Outcomes Research 2018, 10:45-51

Published Date: 10 January 2018

Epidemiology, associated burden, and current clinical practice for the diagnosis and management of Alzheimer’s disease in Japan

Montgomery W, Ueda K, Jorgensen M, Stathis S, Cheng Y, Nakamura T

ClinicoEconomics and Outcomes Research 2018, 10:13-28

Published Date: 28 December 2017

Clinical and economic outcomes of a "high-touch" clinical management program for intravenous immunoglobulin therapy

Zhu J, Kirkham HS, Ayer G, Chen CC, Wade RL, Karkare SU, Robson CH, Orange JS

ClinicoEconomics and Outcomes Research 2018, 10:1-12

Published Date: 19 December 2017